Brooke Kinniburgh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brooke Kinniburgh has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Farihah Ali
Ontario Node of Canadian Research Initiative in Substance Matters, 250 College Street, Toronto, Ontario, M5T 1R8, Canada; Institute for Mental Health Policy Research, Centre for Additions and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario, M5T 3M7, Canada
3 shared publicationsHeather Palis
BC Centre for Disease Control, Vancouver, Canada
3 shared publicationsIesha Henderson
Professionals for Ethical Engagement of Peers, BC Centre for Disease Control, 655 W 12th Avenue, Vancouver, British Columbia, V5Z 4R4, Canada
3 shared publications- Sameer Imtiaz
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada
3 shared publications - Alissa Greer
School of Criminology, Simon Fraser University
2 shared publications - Becca Wood
Simon Fraser University
2 shared publications
Latest Publications
- 21 April 2026
- Published by SAGE Publications in Medical Decision Making
- Vol. 46 (5) , 649-660
Widespread Take-Home Naloxone Use Averted the Majority of Potential Opioid Poisoning Deaths in British Columbia, 2019–2024: A Bayesian Modelling Study
Background: The toxic unregulated drug supply in North America continues to produce high rates of drug deaths. In response, several harm reduction interventions have been introduced and/or expanded, including take-home naloxone (THN). Estimating the impact is challenged by a lack of complete reporting data. Objective: The aim of this study was to estimate the impact of interventions on drug deaths in British Columbia from January 2019 to September 2024. Methods: We extended on a Bayesian hierarchical Markov chain model of drug poisoning events including interventions for overdose prevention sites and opioid agonist treatment. The extended model uses the reported number of THN kits used and distributed and all kits shipped to sites. These data are incorporated into the likelihood to estimate THN kit use during an opioid poisoning event by region and site type. Simulation studies evaluated the model’s performance. Results: The estimated probability of THN kit use during an opioid poisoning event was 42.98% (95% credible interval [CrI]: 41.12–44.84) for kits distributed from community sites and 13.41% (95% CrI: 12.57–14.40) for overdose prevention sites. Correctional centers, pharmacy, and emergency department THN kits all had the lowest probability of use at 0.12% (95% CrI: 0.11–0.13), 1.04% (95% CrI: 0.96–1.13), and 0.65% (95% CrI: 0.60–0.71), respectively. The combined rate of deaths averted was 1,294 (95% CrI: 1,138–1,438) per 100,000 persons who inject drugs, which represents 78% (95% CrI: 76–80) of potential deaths. Conclusion: Despite the increasing toxicity of the illegal drug supply, harm reduction interventions including THN have had a large impact on the number of drug deaths. Estimates of the impact of THN based on reported use alone would greatly underestimate the total impact. Highlights: We developed a novel Bayesian hierarchical model to estimate take-home naloxone (THN) kit use during opioid poisonings using incomplete but complementary program and surveillance data. The model provides site-specific and regional estimates of kit use, highlighting significant differences by site type and geography. Simulation studies show the model can estimate the probability of THN kit use under realistic data limitations, supporting its use in policy evaluation. Public health decision makers can use this method to better assess and optimize harm reduction programs when direct usage data are scarce.
- 21 April 2026
- Published by SAGE Publications in Medical Decision Making
- Vol. 46 (5) , 649-660
Widespread Take-Home Naloxone Use Averted the Majority of Potential Opioid Poisoning Deaths in British Columbia, 2019–2024: A Bayesian Modelling Study
Background: The toxic unregulated drug supply in North America continues to produce high rates of drug deaths. In response, several harm reduction interventions have been introduced and/or expanded, including take-home naloxone (THN). Estimating the impact is challenged by a lack of complete reporting data. Objective: The aim of this study was to estimate the impact of interventions on drug deaths in British Columbia from January 2019 to September 2024. Methods: We extended on a Bayesian hierarchical Markov chain model of drug poisoning events including interventions for overdose prevention sites and opioid agonist treatment. The extended model uses the reported number of THN kits used and distributed and all kits shipped to sites. These data are incorporated into the likelihood to estimate THN kit use during an opioid poisoning event by region and site type. Simulation studies evaluated the model’s performance. Results: The estimated probability of THN kit use during an opioid poisoning event was 42.98% (95% credible interval [CrI]: 41.12–44.84) for kits distributed from community sites and 13.41% (95% CrI: 12.57–14.40) for overdose prevention sites. Correctional centers, pharmacy, and emergency department THN kits all had the lowest probability of use at 0.12% (95% CrI: 0.11–0.13), 1.04% (95% CrI: 0.96–1.13), and 0.65% (95% CrI: 0.60–0.71), respectively. The combined rate of deaths averted was 1,294 (95% CrI: 1,138–1,438) per 100,000 persons who inject drugs, which represents 78% (95% CrI: 76–80) of potential deaths. Conclusion: Despite the increasing toxicity of the illegal drug supply, harm reduction interventions including THN have had a large impact on the number of drug deaths. Estimates of the impact of THN based on reported use alone would greatly underestimate the total impact. Highlights: We developed a novel Bayesian hierarchical model to estimate take-home naloxone (THN) kit use during opioid poisonings using incomplete but complementary program and surveillance data. The model provides site-specific and regional estimates of kit use, highlighting significant differences by site type and geography. Simulation studies show the model can estimate the probability of THN kit use under realistic data limitations, supporting its use in policy evaluation. Public health decision makers can use this method to better assess and optimize harm reduction programs when direct usage data are scarce.
- Open Access
- 26 March 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Access to health and harm reduction services during drug decriminalization in British Columbia, Canada: a mixed-method study
On January 31st 2023, the Canadian province of British Columbia temporarily decriminalized the personal possession of certain illegal drugs up to 2.5&n
- 26 March 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessAccess to health and harm reduction services during drug decriminalization in British Columbia, Canada: a mixed-method study
On January 31st 2023, the Canadian province of British Columbia temporarily decriminalized the personal possession of certain illegal drugs up to 2.5&n
- Open Access
- 26 March 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 151, 105250
Public drug use, policing, and the limits of decriminalization in British Columbia: A mixed methods study
- 26 March 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 151, 105250
Open AccessPublic drug use, policing, and the limits of decriminalization in British Columbia: A mixed methods study
- 11 September 2025
- Published by Wiley in Drug and Alcohol Review
- Vol. 44 (7) , 1856-1865
The Short‐Term Impacts of Decriminalisation of Personal Possession of Select Illegal Drugs on Drug Poisonings in British Columbia, Canada (2015–2023)
Introduction: Canada is in the midst of a crisis featuring drug poisonings. Decriminalisation of personal possession of select illegal drugs was implemented in British Columbia, Canada on 31 January 2023 as one element of a public health response to reduce drug‐related harms. We evaluated the short‐term impacts of decriminalisation on paramedic responses to opioid poisonings and drug poisoning deaths to detect if there were early signals of change. Methods: We sourced population‐based monthly counts of drug poisonings from the provincial emergency services provider and coroners service to compute total and sex‐specific age‐standardised rates per 100,000 (January 2015–December 2023 [97 months pre‐decriminalisation and 11 months post‐decriminalisation]). Generalised additive models in an interrupted time series design were used to evaluate the short‐term impacts of decriminalisation on rates of paramedic responses to opioid poisonings and drug poisoning deaths. Results: Decriminalisation was not associated with an immediate effect ( β [95% confidence interval; CI] −0.078 [−0.318, 0.163]) or trend change ( β [95% CI] −0.022 [−0.082, 0.037]) in the total rate of paramedic responses to opioid poisonings, nor was it associated with an immediate effect ( β [95% CI] −0.165 [−0.477, 0.147]) or trend change ( β [95% CI] −0.010 [−0.082, 0.062]) in the total rate of drug poisoning deaths. These findings were consistent after stratification by sex. Discussion and Conclusions: Decriminalisation of select illegal drugs was not associated with significant changes in drug poisonings in the first 11 months of its implementation. However, the direction of effects was encouraging from a public health standpoint.
- 11 September 2025
- Published by Wiley in Drug and Alcohol Review
- Vol. 44 (7) , 1856-1865
The Short‐Term Impacts of Decriminalisation of Personal Possession of Select Illegal Drugs on Drug Poisonings in British Columbia, Canada (2015–2023)
Introduction: Canada is in the midst of a crisis featuring drug poisonings. Decriminalisation of personal possession of select illegal drugs was implemented in British Columbia, Canada on 31 January 2023 as one element of a public health response to reduce drug‐related harms. We evaluated the short‐term impacts of decriminalisation on paramedic responses to opioid poisonings and drug poisoning deaths to detect if there were early signals of change. Methods: We sourced population‐based monthly counts of drug poisonings from the provincial emergency services provider and coroners service to compute total and sex‐specific age‐standardised rates per 100,000 (January 2015–December 2023 [97 months pre‐decriminalisation and 11 months post‐decriminalisation]). Generalised additive models in an interrupted time series design were used to evaluate the short‐term impacts of decriminalisation on rates of paramedic responses to opioid poisonings and drug poisoning deaths. Results: Decriminalisation was not associated with an immediate effect ( β [95% confidence interval; CI] −0.078 [−0.318, 0.163]) or trend change ( β [95% CI] −0.022 [−0.082, 0.037]) in the total rate of paramedic responses to opioid poisonings, nor was it associated with an immediate effect ( β [95% CI] −0.165 [−0.477, 0.147]) or trend change ( β [95% CI] −0.010 [−0.082, 0.062]) in the total rate of drug poisoning deaths. These findings were consistent after stratification by sex. Discussion and Conclusions: Decriminalisation of select illegal drugs was not associated with significant changes in drug poisonings in the first 11 months of its implementation. However, the direction of effects was encouraging from a public health standpoint.
- 20 August 2025
- Published by Elsevier in Public Health
- Vol. 248, 105915
Decriminalization of drug possession in British Columbia and hospitalizations for opioid poisoning
- 20 August 2025
- Published by Elsevier in Public Health
- Vol. 248, 105915
Decriminalization of drug possession in British Columbia and hospitalizations for opioid poisoning